Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

RET IRD 02

In this page

Clinical Trial

NCT01521793 Completed
RET IRD 02

Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis orRetinitis Pigmentosa (Extension of Study RET IRD 01)

Phase 1
Interventional

Disease

Disease type

Paediatric clinical trials

Retinitis Pigmentosa

Orphan drug recognition

NA

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

01/01/2012

Closing date

01/05/2014

Inclusion criteria :

More

Exclusion criteria :

More

Funding

private

Members involved

Main investigators

Dr Katarina Stingl

Representative

Germany

Low Vision Daily Life and Patients Groups (TWG5), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
Working Group Leader
See more

Prof. Dr. med. Karl Ulrich Bartz-Schmidt

Substitute

Germany

See more

Dr Axel PETZOLD

Netherlands

Neuro-Ophthalmology Rare Diseases (WG2), Research (TWG8)
See more

Dr Susanne KOHL

Substitute

Germany

Genetic Diagnostics (TWG6), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
Working Group Leader
See more

ERN EYE member investigating site

HCP : Principal investigators

Centre for Ophthalmology, University Eye Hospital, Tübingen, Germany

Adress

Department für Augenheilkunde Tübingen Forschungsinstitut für Augenheilkunde Elfriede-Aulhorn-Str. 7

72076 Tübingen

Germany